ArticlePediatric nephrology (Berlin, Germany)2008
Linear growth in pediatric hemodialysis patients.
Article in Pediatric nephrology (Berlin, Germany), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00943995 (TIW Growth Hormone Therapy in Children on Hemodialysis), which is not on this map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
TIW Growth Hormone Therapy in Children on Hemodialysis
Who cites it
7 citing papers in PubMed, 23 citations in OpenAlex.
- Allocation of Kidney Allografts From Donors With Kidney Donor Profile Index <35% and the Impact of Kidney Donor Profile Index Revisions on Access to Transplantation for Children.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026Article
- Predicting pediatric kidney transplant wait times: The unexplored landscape and pre-allocation transplant policies.Pediatric nephrology (Berlin, Germany) · 2024Article
- Hemoglobin level and risk of hospitalization and mortality in children on peritoneal dialysis.Pediatric nephrology (Berlin, Germany) · 2014Article
- Growth in children with chronic kidney disease: 13 years follow up study.Journal of nephrology · 2014Article
- Geographic determinants of access to pediatric deceased donor kidney transplantation.Journal of the American Society of Nephrology : JASN · 2014Article
- Nutritional management and growth in children with chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2013Review
- Clinical outcomes in pediatric hemodialysis patients in the USA: lessons from CMS' ESRD CPM Project.Pediatric nephrology (Berlin, Germany) · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growth is an important outcome in pediatric kidney disease. We aimed to identify factors associated with growth in pediatric hemodialysis (HD) patients. Height standard deviation scores (Ht SDS) of pediatric HD patients with consecutive height measurements in the ESRD Clinical Performance Measures Project were calculated. Multiple linear regression determined the effect of factors on Ht SDS change/year. Four hundred and seven patients were included. Median age was 15.2 years (interquartile range 13.2-16.5 years); 44% were girls, and 27% were black. Of patients observed, 66% had growth hormone (GH) data, and of those, 29% were prescribed GH. Mean change in Ht SDS/year was -0.10+/-0.71. After adjustment, decreasing Ht SDS was associated with younger age (-0.2/year for <13 vs. >or=13 years; p<0.0001), longer duration on dialysis (-0.03/year for >or=6 months vs. <6 months; p<0.01), and higher normalized protein catabolic rate (nPCR) (-0.02/year per 0.1; p<0.05). Improved growth was seen in girls (0.10/year; p<0.01) and in those with lower Ht SDS (0.03/year per 0.5 decrease; p<0.001). Hemoglobin, GH use, and adequacy were associated with neither positive nor negative changes in Ht SDS. Growth retardation while on HD was most pronounced in patients who were young, male, had longer durations on HD, had higher nPCR, and had higher baseline Ht SDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.